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laries is a long standing challenge of tissue engineering. We
recently showed the utility of low level interstitial flow in
guiding the organization of endothelial cells through a 3-D
fibrin matrix-containing covalently bound vascular
endothelial growth factor (VEGF). Here this synergistic
phenomenon was extended to explore the effects of matrix
composition on in vitro capillary morphogenesis of human
blood versus lymphatic endothelial cells (BECs and LECs).
Different mixtures of fibrin and collagen were used in
conjunction with constant concentrations of matrix-bound
VEGF and slow interstitial flow over 10 days. Interestingly,
the BECs and LECs each showed a distinct preference in
terms of organization for matrix composition: LECs orga-
nized the most extensively in a fibrin-only matrix, while BEC
organization was optimized in the compliant collagen-con-
taining matrices. Furthermore, the BECs and LECs pro-
duced architecturally different structures; while BECs
organized in thick, branched networks containing wide
lumen, the LECs were elongated into slender, overlapping
networks with fine lumen. These data demonstrate the
importance of the 3-D matrix composition in facilitating
and coordinating BEC and LEC capillary morphogenesis,
which is important for in vitro vascularization of engineered
tissues.
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In vitro morphogenesis of organized cell structures
constitutes a major common goal among tissue engineers,
particularly endothelial capillary morphogenesis, since in
vitro vascularization remains a serious barrier to transplant-
ing engineered tissues and organs. The approach to reach
this end includes the integration of biochemical, biome-
chanical and cellular components to form functional and
cohesive tissue systems (Griffith and Swartz, 2006). ‘‘In vitro
angiogenesis’’—which broadly defines the transformation
of endothelial cells into tube-like structures on 2-D coated
plates or on/in 3-D gels—has been studied for decades
(reviewed in Davis et al., 2002; Egginton and Gerritsen,
2003; Vailhe et al., 2001), yet the formation of branched,
continuous, stable, and perfused endothelial cell networks
continues to challenge basic scientists and tissue engineers
(Jain et al., 2005). Approaches for artificial vascularization
can be categorized as (A) actuation of vessel sprouting
(angiogenesis) from surrounding tissue into an engineered
tissue matrix post-implantation by releasing angiogenic
growth factors in a diffusion-controlled (Richardson et al.,
2001) or cell-controlled (Ehrbar et al., 2004; Zisch et al.,
2003) manner, and (B) in vitro prevascularization of the
matrix by seeding endothelial cells, potentially along with
other cells for network stabilization, and angiogenic growth
factors in 3-D gels (Black et al., 1998; Hudon et al., 2003;
Levenberg et al., 2005) or on micropatterned surfaces (Dike
et al., 1999), which may then become incorporated into the
vasculature post-implantation (Tremblay et al., 2005). InBiotechnology and Bioengineering, Vol. 96, No. 1, January 1, 2007 167
these approaches, cells and biomolecular cues play key roles
in morphogenesis.
Recent evidence has demonstrated the importance of low-
level interstitial flow in coordinating the organization of
endothelial cells in 3-D cultures. The first studies demon-
strated that interstitial flow could induce both blood and
lymphatic endothelial cell (BEC and LEC) organization into
3-D structures in collagen gels when stimulated with
phorbol 12-myristate 13-acetate (Ng et al., 2004). Sub-
sequent studies in fibrin gels explored how interstitial flow
would affect cell organization under the influence of matrix-
bound vascular endothelial growth factor (VEGF) (Helm
et al., 2005), a potent inducer of angiogenesis and vascular
permeability. In addition, this compound exists in multiple
isoforms, including the predominant matrix-binding
VEGF165 and the soluble VEGF121 (Ferrara et al., 2003).
While VEGF165 has been shown to be more effective in
inducing morphologically relevant angiogenesis than
VEGF121 (Keyt et al., 1996), an engineered fibrin-binding
variant of VEGF121, a2PI1-8-VEGF121, was more effective in
driving proliferation and capillary morphogenesis than
soluble wild-type VEGF121 (Ehrbar et al., 2005; Zisch et al.,
2001). In addition, when applied as an implanted fibrin
matrix in vivo, this matrix-binding variant of VEGF121
produced patent capillary vessels as opposed to the leaky
variety elicited by soluble VEGF121 in the same system
(Ehrbar et al., 2004).
We showed that interstitial flow dramatically synergizes
with this VEGF fusion protein incorporated into fibrin to
produce complex capillary morphogenesis from LECs or
BECs seeded in a 3-D single-cell suspension (Helm et al.,
2005). Moreover, computational studies of VEGF liberation
from the matrix, diffusion, and convection suggested that
the interstitial flow acts to bias and amplify the distribution
of cell-liberated VEGF, creating directional transcellular
protein gradients to which the cells could directionally sense
and respond (Fleury et al., 2006). While this study
introduced a novel mechanism for how interstitial flow
could enhance and direct cell migration and cell-cell
communication, and demonstrated, importantly, that
biomechanical cues can act in synergy with growth factor
cues to affect organization in morphogenesis, it had limited
use for certain tissue engineering applications because the
fibrin cultures were not sustainable over long periods of
time (>6 days). As a temporary wound healing matrix,
fibrin is highly cross-linked and not amenable to remodel-
ing by the cells but rather, by design, readily biodegraded
by the cells; collagen, a more stable matrix for in vitro
purposes, is a physical gel that is merely entangled but not
cross-linked.
Here we seek to further exploit the coordinated action of
slow interstitial flow and matrix-bound VEGF to achieve
blood and lymphatic capillary organization in vitro with
more extensive and stable capillary networks. We altered the
growth matrix itself by adding various amounts of collagen
and changing the relative amounts of fibrin, which allowed
us to extend the time period of observation to at least168 Biotechnology and Bioengineering, Vol. 96, No. 1, January 1, 200710 days. As before, we saw drastic synergy between the
biophysical (organizational) cue of flow and the biochemical
(growth) cue of matrix-bound VEGF. Interestingly, we
found that the two different endothelial cell populations
presented by the blood and lymphatic lineages behaved
differently in the matrices tested and organized preferen-
tially in different matrices. In addition, the structures that
formed differed in architecture: LECs organized into
elongated structures with slender lumen, while BECs
produced broad, complex branching structures-containing
wide lumen. These data together highlight the importance
of matrix selection in the study and exploitation of
endothelial cell organization for both basic studies of
endothelial cell biology as well as tissue engineering
applications, and demonstrate a new extent to which
organized and interconnected capillary networks can be
achieved in vitro.Materials and Methods
Cell Culture
Human dermal BECs and LECs, isolated from neonatal
foreskins using the lymphatic-specific receptor LYVE-1,
were a kind gift from Dr. Mihaela Skobe (Podgrabinska
et al., 2002) and used at passages 7–9. These cells were
expanded on gelatin-coated flasks in basal endothelial cell
medium (Cambrex, Walkersville, MD) supplemented with
20% fetal bovine serum (Invitrogen, Carlsbad, CA) and
1 mg/ml hydrocortisone acetate, 25 mg/ml dibutyril cAMP,
and 1% penicillin, streptomycin, amphotericin mixture
(all from Sigma, St. Louis, MO) in a 378C/5% CO2
incubator.Matrix Formulations
A mutant of recombinant human VEGF121, a2-PI1–8-
VEGF121, was created as described previously (Zisch
et al., 2001). The resulting bi-domain fusion protein
contained mature human recombinant VEGF121 and the
factor XIIIa substrate sequence from a2-plasmin inhibitor,
NQEQVSPL, at the amino terminus. AlexaFluor 647-
modified human fibrinogen (Molecular Probes, Eugene,
OR) was combined with unlabeled human fibrinogen
(Sigma) at a mass ratio of 1:25 (labeled to unlabeled),
producing the base fibrinogen solution used for all the
matrices. Gel matrices were prepared from a mixture
containing 100 ng/ml a2-PI1–8-VEGF121, 2 U/ml human
thrombin (Sigma), 2.5 mM CaCl2 (Fisher, Fairlawn, NJ),
and 2 U/ml human factor XIII (Baxter, Deerfield, IL) along
with final concentrations of type I collagen and fibrinogen
shown in Table I. LECs or BECs were suspended in this
solution at 1.5 106 cells/ml and the mixture was pipetted
into an interstitial flow culture chamber and allowed toDOI 10.1002/bit
Table I. Composition and stiffness of the four matrices tested.
Matrix
A B C D
Collagen (mg/ml) 1 1 0.5 —
Fibrinogen (mg/ml) 2 1 2.5 3
Stiffness (Pa) 366 144 97 22 411 93 171 17
Permeability (cm2 109) 12.0 4.0 12.0 4.0 3.3 0.5 1.4 0.5polymerize, as described previously (Ng and Swartz, 2003).
The chambers were maintained, in cell culture medium,
for 18–24 h under static conditions to allow for cell
attachment.Application of Interstitial Flow
The radial flow chamber was employed for a 3-D flow
environment. It consisted of a cylindrical central core with a
radius of 0.16 cm and an outer ring with a radius of 0.56 cm
(both composed of porous polyethylene) and a vertical
internal height of 0.16 cm (described in Ng et al., 2004). To
initiate flow through the radial flow chamber cell culture
medium, supplemented with 200 KIU/ml aprotinin
(Sigma), was slowly pumped through the gel using a six-
roller peristaltic pump (Cole Parmer, Vernon Hills, IL). This
slow interstitial flow drove an average velocity of 4.5 mm/s
through the gel (15.8 mm/s in the inlet and 2.4 mm/s at the
outlet) with a measured pressure head of 2 cm of water.
Static controls were maintained in the interstitial flow
chambers with the same supplemented culture medium but
without being connected to the pump. All experimental
conditions were maintained for 10 days at 378C and 5% CO2
(2–4 experiments were performed for each matrix with each
cell type).Analysis
Media samples from each experiment were collected 24 h
after the imposition of interstitial flow. Commercially
available ELISA kits were used to estimate secreted amounts
of human matrix metalloproteinase (MMP)-9 (Calbiochem,
San Diego, CA) and MMP-3 (R&D Systems, Minneapolis,
MN).
After the 10 days of culture, the gels were fixed in 4%
paraformaldehyde and stained with 200 nM phalloidin
conjugated with AlexaFluor488 fluorescein for f-actin and
Sytox Orange for nuclei (both from Molecular Probes).Image Acquisition and Quantification
Images of the matrix and endothelial cells were collected
using a laser scanning confocal microscope (Leica LCS SP2).Helm et al.: EThe collagen contained within the matrix was visualized
using confocal reflectance, exploiting the reflective qualities
of the collagen fibers under 488 nm laser illumination (Ng
et al., 2005). Two sets of 3-D image stacks that spanned a
depth of 40 mm and a length of 1.46 mm were collected in
sequence from the inner core to the outer ring of each
chamber. The volume occupied by multi-cellular organiza-
tions was measured and correlated for the resulting sets of
stacks, based on pixel densities collected by Volocity
(Improvision, Lexington, MA) using a size threshold that
eliminated the counting of rounded cells. In addition, 2-D
projections were created from these stacks to analyze other
structure characteristics. The shape of the structures was
assessed by measuring the projected area and perimeter of
each structure (Volocity) and computing their ratio. A size
threshold of 300 mm3 was used to preclude the individual
rounded cells. The extent of organization was also deter-
mined from the 2-D projections. Two highly organized
regions, each spanning 40% of the radial distance, were used
from each sample to manually count the number of cells
involved in each structure.Gel Stiffness Measurements
A Paar Physica MCR Rheometer (Anton Paar, Graz,
Austria) was used to measure the viscoelastic properties
of matrices created with the same formulations that were
used in the flow experiments. The matrix constituents
were mixed, as detailed above, and pipetted directly onto the
stainless steel cone and plate of the rheometer which
were maintained at 378C in a humidified chamber. The cone
measured 50 mm in diameter with a 18 angle. Measurements
were collected over 15 s every 10min for a total period of 2 h;
the matrix was allowed to relax during the 10 min intervals.
The rheometer was operated in oscillating mode at 1% strain
and a frequency of 10 s1. The storage modulus G0 was
calculated by the MCR US200 software and was used to
represent the stiffness of the tested matrices. Data shown in
Table I indicate the mean SEM.Gel Permeability Measurements
The hydraulic permeabilities of each gel formulation were
assessed without cells. An in-line manometer was included
between the feed pump and flow chamber inlet. Cell culture
medium was perfused through the flow chamber while
housed in a 5% CO2, 378C incubator. For each of four flow
rates, the system was allowed to run for 1 h and the resulting
pressure differential was measured. Darcy’s law, v¼ (K/
m)rP, was used to calculate the permeability K, where v is
the average velocity, rP is the pressure gradient dP/dr, and
m is the fluid viscosity (measured as 0.7657 cP using an
Ubbelohde viscometer at 378C). Because of the radial flow
geometry, this was rewritten as Q¼B(K/m)DP, wherengineered Capillaries in VEGF-Fibrin-Collagen Matrices With Flow 169
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DP¼ inlet pressureoutlet pressure, B¼ 2ph/ln (ro/ri) and
h¼ chamber height, ro¼ outer radius, and ri¼ inner radius.
In this way, the slope of the Q versus DP line was used to
calculate K.Statistics
Comparisons of the measurements among matrix formula-
tions within each cell type (LEC or BEC) were conducted
using the Kruskal–Wallis analysis of variance followed by
Dunn’s comparison. Comparisons between cell types for a
given matrix were made using a two-tailed Student’s t-test
while the error bars shown correspond to mean SEM.Results
With the exception of matrix B, the four matrix formula-
tions had equal total protein concentrations but varied in
terms of their relative amounts of fibrinogen and collagen
according to Table I. Each matrix contained the same
concentration of a2-PI1–8-VEGF121 (100 ng/ml), thrombin
(2 U/ml), CaCl2 (2.5 mM), and factor XIII (2 U/ml). These
differences in extracellular matrix (ECM) composition
translated into a range of stiffness values, as indicated by the
storage modulus, G0, from 100 to 400 Pa; matrices A and C
had similar high values, and matrices B and D had similar
low values. Permeability values for these matrices (Table I)Figure 1. Structural architecture of the four matrices described in Table I. Panels A
fluorescently labeled fibrinogen is indicated in red, while confocal reflectance shows the
fibrinogen. The smaller individual red and white channels show each matrix constituent
170 Biotechnology and Bioengineering, Vol. 96, No. 1, January 1, 2007showed that matrices A and B (the ones with the most
collagen) had the highest permeability and matrix D (with
no collagen) the lowest.
Images of the fibrous gel structures were collected using
confocal microscopy, allowing for their assessment in a
hydrated state, and eliminating potential artifacts of analysis
by electron microscopy (Pedersen and Swartz, 2005). A
comparison of the architectures of each matrix (Fig. 1)
demonstrate that fiber density increased with increasing
fibrinogen concentration, consistent with earlier findings
(Herbert et al., 1998; Ryan et al., 1999). The collagen present
in matrices A–C appears as a fibrous network that
interpenetrates within the fibrin network, producing a
dense complex growth environment for the cells.
Interestingly, BECs and LECs each organized differently
in the four different matrices (Fig. 2). Specifically, while
BECs organized better in matrices with higher collagen
concentrations (and higher compliance), LEC organization
was best in the fibrin-only matrix (which was also a more
compliant gel). After 10 days under interstitial flow, BECs
formed extensively branched structures in matrices A and B,
many of which spanned large distances (>400 mm),
particularly in the case of matrix B. In matrices C and D,
BECs failed to organize substantially. In contrast, LEC
organization was observed in matrices B and D, but not
in A or C. Additionally, no significant difference in cell
organization was detected as a function of radial position
(data not shown).
These differences were quantified in two ways: first, the
volume occupied by the structures reflected the overall–D show confocal images of the fibrous structure in matrices A–D, respectively. The
presence of collagen fibers in gray that are well dispersed within the predominant
separately. Scale bar¼ 10 mm.
DOI 10.1002/bit
Figure 2. Organizational behavior of LECs and BECs in matrices A–D under interstitial fluid flow. A: 2-D projections of confocal stacks showing endothelial organization as
indicated; Green¼ f-actin; blue¼ nuclei; scale bar¼ 80 mm. B: The total percent volume occupied by multi-cellular structures in each of the four matrices, which reflects the
degree of organization (i.e., how many structures form), demonstrates that matrix B was optimal for BEC organization while matrix D was optimal for LEC organization. P< 0.05
using Kruskal–Wallis analysis with Dunn’s post-test. C: Multi-cellular organizations were assessed for the average cell number per structure to quantify the extent of endothelial
organization (i.e., how big the structures are). Lines on scatter plot indicate median values for each data set. This also showed that matrices B and D were optimal for BEC and LEC
organization, respectively. In all matrices, interstitial fluid flow moved from right to left.degree of organization (Fig. 2B); and second, the counts of
cells per structure reflected the extent of organization
(Fig. 2C). For BECs, matrices A and B provided the best
environment for both degree and extent of organization
(Fig. 2B); however, matrix B elicited a better overall response
in both degree (Fig. 2B) and extent (Fig. 2C) of organization.
BECs contained within matrices C or D failed to organize
significantly. In contrast, the degree of LEC organization was
best in matrices B and D (Fig. 2B), but only matrix D showed
an enhanced extent of organization. In other words,
although several matrices appeared to support LEC
organization, only matrix D supported the formation of
structures more than 2–3 cells in size (Fig. 2C). Neither cell
type organized to any significant degree or extent in matrix
C, which had the combination of low collagen concentration
but high stiffness compared to the other matrices (note that
matrix D had no collagen at all, but it was twice as
compliant).
Aside from preferring different matrix compositions for
optimal organization, the LEC and BEC structures that
formed had markedly different morphologies. LEC struc-Helm et al.: Etures were very slender and elongated, similar to that seen in
previous, shorter duration studies (Helm et al., 2005), while
BEC structures were broader with more densely packed cells.
Closer examination of the LEC and BEC structures in higher
magnification images revealed more detail about their
architecture (Fig. 3). The BEC structures that formed were
reminiscent of in vivo vascular endothelium with cells
tightly packed and aligned along the edge of broad open
lumen spaces (Fig. 3A–D). In vitro LEC structures also
mimicked their in vivo architecture, with adjacent cells
overlapping in the slender organizations they formed
(Fig. 3E) and with slight lumen (Fig. 3F).
We attempted to quantify these differences in shape by
compiling the ratio of each structure’s area to its perimeter
when projected into a 2-D image. In this way, long and
slender structures would have a smaller ratio value than
broad structures. When comparing the average of these
ratios, we found that BEC structures had a significantly
higher value than LEC structures, indicating that these
structures were indeed broader than those produced by
LECs (Fig. 3G).ngineered Capillaries in VEGF-Fibrin-Collagen Matrices With Flow 171
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Figure 3. High magnification confocal images show that the BEC structures
contained broad lumen while LEC structures produced very fine lumen in each of their
most organizationally conducive matrices. A: BECs organized in broad, complex
structures in matrix A. B: BECs in matrix A showing cell enclosed lumen void of
matrix fibers, shown in red. C: BECs organized in broad complex structures in matrix B.
D: Confocal images of BECs in matrix B showing enclosed lumen void of matrix fibers.
E: LECs organize in long slender branched structures in matrix D. F: LECs in matrix D
showing fine cell enclosed lumen void of fibers. Green¼ f-actin; blue¼ nuclei; red -
¼matrix fibers. Panels A, C, and E scale bar¼ 40 mm; panels B, D, and F scale bar¼
10 mm. G: To characterize shape of structures that formed, the total structure area and
perimeter were measured in 2-D projections of 3-D stacks. For each cell type in its
optimal matrix formulation, the area-to-perimeter ratios were tabulated and averaged;
P< 0.05 using a Student’s t-test.
Figure 4. BECs produced significantly less MMP-9 then LECs in matrices A and
B while MMP-3 expression was consistent across cell types and matrices. A: MMP-3
expression measured in flow chamber effluent medium. LECs indicated by white bars
and BECs indicated by black bars. B: MMP-9 expression measured in flow chamber
effluent media. P< 0.005 BEC versus LEC as determined by Student’s t-test.
172 Biotechnology and Bioengineering, Vol. 96, No. 1, January 1, 2007In order to determine whether the different matrices
differentially affected the proteolytic activity of the
embedded cells, we also measured expression level of
relevant MMPs. When the expression of MMP-3 was
assessed, little difference was seen across the LEC population
when comparing the results of the different matrices
(Fig. 4A). The BECs showed some differences (although
not statistically significant)—namely that MMP-3 secretion
was notably higher in matrix D, which was the only matrix
with no collagen. However, this was unrelated to organiza-
tion, since BECs neither organized in matrix D nor in matrix
C, where MMP-3 secretion by BECs was low. MMP-9
secretion, however, was significantly and substantially
different between LECs and BECs in matrices A and B
(Fig. 4B); interestingly, these were the matrices with the
most collagen, so the LEC response of MMP-9 secretionmay
reflect attempts by LECs to remodel those matrices with
more collagen as compared to matrices C and D. In contrast,
BECs secreted the most MMP-9 in matrices C and D, where
they did not organize; again, this may reflect an attempt to
remodel their surroundings to make them more optimal for
cell organization.Discussion
We show here that LECs and BECs organize into capillaries
differentially when cultured in matrices containing varying
amounts of collagen and fibrin, under the influence of both
matrix-bound VEGF and interstitial flow. Specifically, LECs
organized best in the fibrin-only matrix (and, interestingly,
the one with the lowest hydraulic permeability), and formed
long, slender, and overlapping structures, while BECs
organized best in collagen-fibrin mixtures that were the
most permeable to fluid movement and formed densely
cellularized branched tubes. For both cell types, more
compliant matrices were more conducive to capillaryDOI 10.1002/bit
morphogenesis. These differences were not apparently due
to differences in soluble proteases secreted by the cells or in
the amounts of VEGF released from the matrix, implying
that the cell interactions with the matrix constituents, as well
as possibly in response to the resistance to fluid flow though
the matrix, were largely responsible for the differences in
organizational behavior seen.
The ECM serves multiple roles, acting as a structural
support, a reservoir for biochemical signals, and as an
actuator itself of both chemical and mechanical stimuli.
Several cytokines such as VEGF, heparin, and basic
fibroblast growth factor are known to be sequestered or
stored in the ECM for use by cells in their presence
(Fairbrother et al., 1998; Fannon et al., 2000). Furthermore,
the constituents that comprise the matrix can themselves act
to affect the cells it supports. As Feng et al. (1999) point out,
the growth of endothelial cells in contact with one matrix
constituent or another, namely collagen or fibrin, can
drastically affect which integrins they produce and subse-
quently the signaling pathways that can be triggered. In
addition, Jalali et al. (2001) demonstrated the need for
integrin–ECM interactions in order for proper transmission
of mechanotransduction signaling pathways in endothelial
cells. Both studies highlight the role that the particular ECM
elements play in communicating with their resident cells.
Generally, the ECM plays a key role in the communication
scheme of the cells within, whether they be assessing their
surrounding environment and reacting accordingly or
communicating with other nearby cells.
The matrices utilized in this study were patterned after the
ECM matrix present during the wound healing response.
Under these circumstances, fibrin and collagen serve as
provisional matrices for the infiltration of inflammatory
cells and reorganizing endothelial cells. The initial presence
of fibrin (in the form of a clot) is replaced gradually, but over
a brief time period, by the infiltration of collagen produced
by invading fibroblasts (Clark et al., 1995). Thus, during this
wound healing process both matrix elements are present at
once, providing the support structure for regenerating
vasculature. Consequently, the use of matrices with varying
proportions of fibrin and collagen provide the endothelial
cells with an environment reminiscent of what can occur in
some in vivo situations.
Although the biomolecular environment has been
demonstrated to play a key role in the numerous studies
exploring the organization of endothelial cells in vitro, the
matrix itself also serves a crucial role that should be
considered (Pepper et al., 1996; van Hinsbergh et al., 2001).
Here we see that the choice of matrix alone can determine
whether endothelial cells will organize into complex
capillary structures or remain as individually suspended
cells in a gel, even when stimuli proven to yield organization
are applied. As has been demonstrated by recent studies,
interstitial flow is a strong inducer of endothelial cell
organization in both fibrin and collagen gels, and synergizes
with VEGF in driving capillary morphogenesis (Helm et al.,
2005; Ng et al., 2004). Exploiting this phenomenon, whileHelm et al.: Evarying the constituents of the matrix, produced an
interesting panel of results. In general, BECs and LECs
organized best in matrices that were more compliant—
matrices B and D, respectively. Previous work by Nehls
and Herrmann (1996), as well as Urech et al. (2005)
highlighted the morphogenic preference that both venous
and arterial endothelial cells had for more compliant fibrin
matrices. These softer matrices, when explored in vitro, not
only allow for cell organization on the surface of fibrin gels
but also allow for invasion and organization within its
interior to a degree not seen in stiffer matrices (Nehls and
Herrmann, 1996; Vailhe et al., 1998; van Hinsbergh et al.,
2001).
The fibrin and collagen content of eachmatrix explored in
this study differed in compliance and permeability, and
facilitated cell–matrix interactions through integrins that
elicit unique functions and cell signaling events (Boudreau
and Jones, 1999). Certainly, the role of the matrix com-
ponents as structural regulators of the cellular organization
cannot be overlooked. Interestingly, while the overall
protein content of the matrices differed in only one
formulation, the calculated permeabilities were different
across all four. These values generally corresponded with
previously collected data (e.g., the permeability of a 3 mg/ml
fibrin gel was on the order of 109 cm2 (Sjoland, 2005)). In
addition, the permeability values appeared to correlate with
the overall collagen content of each matrix formula, where
the matrices with the highest permeability, A and B, had the
highest collagen content, and decreases in the collagen
resulted in an increase in overall permeability. We found
that BECs and LECs each favored different matrix con-
stituents to elicit their greatest degree of organization.
Matrix B, favored by BECs, contained an equal proportion
of both collagen and fibrin and displayed the highest
hydraulic permeability, while matrix D, the LEC-preferred
matrix, contained only fibrin and displayed the lowest
permeability. Thus, a combination of biophysical and
molecular cues contribute to the differential organization of
each cell type, and it is possible that LECs respond to a
higher resistance to fluid flow as a functional driver. This is
consistent with earlier findings that interstitial fluid flow was
an important driver of lymphatic organization in regener-
ating mouse skin (Boardman and Swartz, 2003; Rutkowski
et al., 2006).
These results are also interesting in light of wound healing
events in vivo, where blood angiogenesis occurs within a few
days, when the fibrin clot is still intact but collagen is also
present (Singer and Clark, 1999). However, lymphangio-
genesis begins many days later (Rutkowski et al., 2006),
when the matrix has likely remodeled drastically. Since the
overall stiffness values of these matrices were quite similar,
the differences in cell behavior within them could also have
been influenced by their differences in permeability as well
as the nature of the matrix components themselves. The
primary means by which cells interact with their surround-
ing ECM is through integrins which are specific to particular
constituent molecules. Endothelial cells possess integrins,ngineered Capillaries in VEGF-Fibrin-Collagen Matrices With Flow 173
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such as avb3 and a2b1, which are specific to fibrin and
collagen, respectively (Albelda et al., 1989; Brooks et al.,
1994; Herrick et al., 1999). In addition, the responsiveness of
integrins to stimulation by VEGF can also result in added
capillary morphogenesis (Chavakis et al., 2004; Hall and
Hubbell, 2004). Here the demonstrated preference of LECs
and BECs for different matrix constituents in which to
organize may be attributed to the action of integrins and
their potential interaction with other cell receptors.
Since the different matrix compositions have multiple
differences in terms of properties that can affect cell
organization—including mechanical properties, integrin
ligand presentation, proteolytic sensitivity, cell migration
strategy, and cytokine storage and presentation—it is
difficult to speculate the reasons why the two cell types
organized optimally in each of the specific matrices that they
did. The interstitial fluid velocity used in the experiments,
4.5 mm/s, was higher—but within less than an order of
magnitude—as that measured previously in vivo (Chary
and Jain, 1989; Dafni et al., 2002). Furthermore, as has been
demonstrated recently, interstitial flow through a cell-
containing 3-D matrix has the ability to distort the
pericellular distribution of cell-produced cytokines and
proteases, which would affect both their autocrine and
paracrine signaling and thus, presumably, alter their
organizational behavior (Fleury et al., 2006; Helm et al.,
2005).
A variety of proteases are expressed by endothelial cells
and are involved in their migration and organization within
the ECM (Haas, 2005). The LEC and BEC organizations we
observed within the fibrin and fibrin-collagen blends was
certainly proteolytically controlled, as seen in vivo in similar
matrices (Cassell et al., 2002). Although we did not
exhaustively explore the exact proteolytic signatures of
the LECs and BECs during organization, we did assess two
candidate MMPs that were likely to be involved in the
organization process. The cell-produced proteases that are
responsible for VEGF liberation from the matrix and,
ultimately, cell organization may have caused the differences
seen in LEC and BEC organization. Although direct
measurement of the free (soluble) VEGF released showed
no significant differences among all the conditions (data not
shown), the presence of proteases in the organization
phenomenon required further exploration. We examined
MMP-3 and -9 because of their active roles in angiogenesis
(Pepper, 2001) and their ability to degrade the utilized
matrix components (Bini et al., 1999; Nguyen et al., 2001).
However, the relative expression of these soluble MMPs did
not lend insight into the mechanistic differences in cell
behavior between the different matrices. We found that
MMP-3 was secreted in similar levels by LECs across all
matrices, but not in BECs, where (1) MMP-3 secretion was
generally lower than that by LECs and (2) MMP-3 secretion
was notably (but not significantly) higher inmatrix D, which
was the only matrix with no collagen. Thus, it is likely that
MMP-3 release by BECs (or lack thereof) may be partly
regulated by collagen binding. Furthermore, since BECs res-174 Biotechnology and Bioengineering, Vol. 96, No. 1, January 1, 2007ponded best to collagen-containing matrices while LECs
responded best the fibrin-only matrix, it is interesting to
note that BECs secreted the most MMP-9 in matrices with
the least collagen (C and D, where BEC organization was
poorest), while LECs secreted the most MMP-9 in matrices
with the most collagen (A and B, where LEC organization
was poorest). Thus, MMP-9 expression may indicate an
attempt by the endothelial cells to remodel their ECM in
order to make their environments more conducive to
morphogenesis.
In summary, these data emphasize the importance of
matrix selection in the success of in vitro vascularization of
3-D tissue constructs. More specifically, compliant matrices
composed of a blend of collagen and fibrin or just fibrin
alone are well suited for supporting blood and lymphatic
capillary morphogenesis, respectively. The ultimate func-
tionality of these structures has yet to be determined, but
further analysis of their role in facilitating tissue oxygenation
(Jain et al., 2005) would be beneficial to the ultimate use of
the described technique in vascularizing engineered tissues.
Whether governed by specific interactions with the matrix
constituents through mechanical and/or chemical inter-
actions or variations in the cell produced proteolytic
environment, the data presented highlights behavioral
differences between the lymphatic and blood endothelial
cell populations. These variations in behavior must be
considered when designing tissue engineered systems that
will need blood and lymphatic vasculature to ultimately
become properly integrated into its intended in vivo
location.
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